Alterations in NK cell phenotype in relation to liver steatosis in children with chronic hepatitis C

Inflammation

Volumn 36, Issue 5, 2013, Pages 1004-1012

  Mania, Anna ^a   Kaczmarek, Mariusz ^a   Kemnitz, Paweł ^a   Mozer Lisewska, Iwona ^a   Sikora, Jan ^a   Figlerowicz, Magdalena ^a,b   Woåniak, Aldona ^a   Mazur Melewska, Katarzyna ^a   Służewski, Wojciech ^a   Zeromski, Jan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Higher Vocational State School of Stanis aw Wojciechowski   (Poland)

Author keywords

children; chronic hepatitis C; liver fibrosis; liver steatosis; NK cell receptors

Indexed keywords

APRI PROTEIN; ASPARTATE AMINOTRANSFERASE; CD158I ANTIGEN; CD56 ANTIGEN; CELL MARKER; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KIR PROTEIN; KIR2D PROTEIN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FATTY LIVER; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MALE; METAVIR SCALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; RATING SCALE; SCHOOL CHILD; THROMBOCYTE;

HEPATITIS C VIRUS;

ADOLESCENT; ANTIGENS, CD56; CHILD; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KILLER CELLS, NATURAL; LIVER CIRRHOSIS; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, KIR; RECEPTORS, KIR3DL1;

EID: 84885178034     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9632-0     Document Type: Article

References (19)

1. Mania, A., P. Kemnitz, M. Figlerowicz, I. Mozer-Lisewska, A. Kowala-Piaskowska, A. Woźniak, and W. Słuzewski. 2012. Clinical picture and liver histology of chronic hepatitis C in children. Infectious Diseases in Clinical Practice 20: 141-147.
2. Moretta, L., G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, M.C. Mingari, and A. Moretta. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunology Reviews 214: 219-228.
3. Doherty, D.G., S. Norris, L. Madrigal-Estebas, G. McEntee, O. Traynor, J.E. Hegarty, and C. O'Farrelly. 1999. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. Journal of Immunology 163: 2314-2321.
4. Varchetta, S., D. Mele, S. Mantovani, B. Oliviero, E. Cremonesi, S. Ludovisi, G. Michelone, M. Alesani, R. Rosati, M. Montorsi, and M.U. Mondelli. 2012. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 56: 841-9.
5. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
6. Oliviero, B., S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, D. Mavillo, F. De Filippi, S. Bruno, and M.U. Mondelli. 2009. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160.
7. Radaeva, S., R. Sun, B. Jaruga, V.T. Nguyen, Z. Tian, and B. Gao. 2006. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis-factor related apoptosis-inducing ligand-dependent manners. Gastroenterology 130: 435-452.
8. Livingstone, S.E., H. Deubner, D.L. Burden, B.J. McMahon, C.E. Homan, L.J. Townshend-Bulson, M.G. Bruce, T.W. Hennessy, J.L. Wiliams, and D.R. Gretch. 2010. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C. Canadian Journal of Gastroenterology 24: 445-451.
9. Fukasawa, M., Y. Tanaka, S. Sato, Y. Ono, Y. Nitahara-Kasahara, T. Suzuki, T. Miyamura, K. Hanada, and M. Nishijima. 2006. Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein. Biological and Pharmaceutical Bulletin 29: 1958-1961.
10. Okuda, M., K. Li, M.R. Beard, L.A. Showalter, F. Scholle, S.M. Lemon, and S.A. Weinman. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122: 366-375.
11. Lonardo, A., S. Ballestri, L.E. Adinolfi, E. Violi, L. Carulli, S. Lombardini, F. Scaglioni, M. Ricchi, G. Ruggiero, and P. Loria. 2009. Hepatitis C virus infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. Canadian Journal of Gastroenterology 23(4): 273-278.
12. Adinolfi, L.E., M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero. 2001. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358-1364.
13. Wai, C.T., J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram, and A.S. Lok. 2003. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526.
14. Delgado-Borrego, A., D. Healey, B. Negre, M. Christofi, S. Sabharwal, D.A. Ludwiga, T. Raymond, R.T. Chung, and M.M. Jonas. 2010. The influence of body mass index on outcome of pediatric chronic hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition 51: 191-197.
15. Kremer, M., I.N. Hines, R.J. Milton, and M.D. Wheeler. 2006. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 44: 216-227.
16. Wen, C., X. He, H. Ma, N. Hou, C. Wei, T. Song, Y. Zhang, L. Sun, Q. Ma, and H. Zhong. 2008. Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D. Cellular & Molecular Immunology 5: 475-478.
17. Castriconi, R., C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Morreta. 2003. Transforming growth factor beta1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proceedings of the National Academy of Science of the Unite States of America 100: 4120-4125.
18. Suppiah, V., S. Gauderi, N.J. Armstrong, K.S. O'Connor, T. Berg, M. Weltman, M.L. Abate, U. Spengler, M. Bassedine, G.J. Dore, W.L. Irving, E. Powell, M. Hellard, S. Riodan, G. Matthews, D. Sheridan, J. Natterman, A. Smedile, T. Muller, E. Hammond, D. Dunn, F. Negro, P.Y. Bochud, S. Mallal, G. Ahlenstiel, G.J. Stewart, J. George, D.R. Booth, and International Hepatitis C Genetics Consortium (IHCGC). 2011. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med. 8: e1001092.
19. Golden-Mason, L., K.M. Bambha, L. Cheng, C.D. Howell, M.W. Taylor, P.J. Clark, N. Afidhal, H.R. Rosen, and Virahep-C Study Group. 2011. Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology 54: 1559-1569.